Article
Human breast cancer growth inhibited in vivo by a dominant negative pleiotrophin mutant.
The Journal of biological chemistry - 4 Jul 1997
Zhang N, Zhong R, Wang Z Y, Deuel T F
Abstract excerpt
Pleiotrophin (PTN) is a recently described 18- kDa heparin binding growth/differentiation factor. It also is a proto-oncogene; cells transformed by the Ptn gene form highly angiogenic tumors when implanted into the nude mouse. PTN may be an important regulator of transformation in other tumors, b...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
